Lobbyist Insight

Lobbyist

Rachel Cottle Latham

0 clients across 0 states · $17,530 disclosed · 3 bills

When it was paid
2024: $4k242025: $14k252026: $18426$14k

Bills

BillPositionForStateSession
0—Pharmaceutical Research and Manufacturers of America (PhRMA)Maine2026-06
0—Pharmaceutical Research and Manufacturers of America (PhRMA)Maine2025-09
0—Pharmaceutical Research and Manufacturers of America (PhRMA)Maine2025-06
0—Pharmaceutical Research and Manufacturers of America (PhRMA)Maine2025-05
0—Pharmaceutical Research and Manufacturers of America (PhRMA)Maine2025-04
0—Pharmaceutical Research and Manufacturers of America (PhRMA)Maine2025-03
0—Pharmaceutical Research and Manufacturers of America (PhRMA)Maine2025-02
0—Pharmaceutical Research and Manufacturers of America (PhRMA)Maine2025-01
0—Pharmaceutical Research and Manufacturers of America (PhRMA)Maine2024-11
0—Pharmaceutical Research and Manufacturers of America (PhRMA)Maine2024-10
0—Pharmaceutical Research and Manufacturers of America (PhRMA)Maine2024-08
0—Pharmaceutical Research and Manufacturers of America (PhRMA)Maine2024-05
0—Pharmaceutical Research and Manufacturers of America (PhRMA)Maine2024-03
1829—Pharmaceutical Research and Manufacturers of America (PhRMA)Maine2024-03
0—Pharmaceutical Research and Manufacturers of America (PhRMA)Maine2024-02
1165—Pharmaceutical Research and Manufacturers of America (PhRMA)Maine2024-02
1829—Pharmaceutical Research and Manufacturers of America (PhRMA)Maine2024-02
1165—Pharmaceutical Research and Manufacturers of America (PhRMA)Maine2024-01
1829—Pharmaceutical Research and Manufacturers of America (PhRMA)Maine2024-01

Disclosed figures are what the state publishes, not total billings. In Alaska and New York the figure is a contract rate rather than a payment.